The Effects of Resveratrol on Menopausal Cardio-metabolic Changes: A Systematic Review.
Study Design
- Tipo de estudio
- Systematic Review
- Población
- Menopausal women
- Intervención
- The Effects of Resveratrol on Menopausal Cardio-metabolic Changes: A Systematic Review. None
- Comparador
- Placebo or no treatment
- Resultado primario
- Cardiometabolic changes in menopausal women
- Dirección del efecto
- Positive
- Riesgo de sesgo
- Unclear
Abstract
INTRODUCTION: Menopause is known as a stage in a woman's natural life cycle in which menstrual periods permanently stop with developing age. This review aims to review the modulating mechanistic effects of resveratrol (RSV) on cardiometabolic changes associated with menopause. METHODS: To identify published studies before January 12, 2025, a comprehensive search was conducted across various electronic databases, such as Web of Science, PubMed/MEDLINE, Embase, Scopus, and the Cochrane Library. Based on the study's objectives, two reviewers independently performed data extraction to ensure accuracy and reduce bias. The extracted data were subsequently reviewed. RESULTS: RSV has reductive effects on blood pressure, improves endothelial function, and enhances insulin-stimulated glucose uptake. It also decreases fasting blood glucose levels, insulin levels, total cholesterol, triglycerides, and adipocyte hypertrophy. Increased estradiol levels correlate with improved cerebrovascular function and enhanced neurovascular coupling. However, the effects on body weight, body mass index (BMI), and lipid metabolism are inconsistent; some studies reported reductions in fat volume and changes in thermogenesis-related gene expression. Moreover, total antioxidant capacity (TAC) and malondialdehyde (MDA) levels increase. While RSV demonstrates potential benefits for vascular function and metabolic regulation, further research is necessary to determine its long-term efficacy. DISCUSSION: The findings align with existing evidence on RSV's vascular and metabolic benefits, underscoring its complementary therapeutic potential. Limitations, like bioavailability, differences in patient characteristics, and inconsistent lipid outcomes, call for standardized and long-term studies. CONCLUSION: RSV, as a phytoestrogen, increases estrogen levels in the intervention groups. RSV shows potential effects in modulating the most studied menopausal cardio-metabolic changes.
TL;DR
RSV shows potential effects in modulating the most studied menopausal cardio-metabolic changes, and increases estrogen levels in the intervention groups, underscoring its complementary therapeutic potential.
Used In Evidence Reviews
Similar Papers
Journal of cardiovascular pharmacology · 2009
Grapes, wines, resveratrol, and heart health.
Alcoholism, clinical and experimental research · 2009
Alcohol in moderation, cardioprotection, and neuroprotection: epidemiological considerations and mechanistic studies.
Ageing research reviews · 2010
Ageing and neurodegenerative diseases.
Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association · 2013
Antioxidant effects of resveratrol in cardiovascular, cerebral and metabolic diseases.
Nutrients · 2017
Effects of Resveratrol on Cognitive Performance, Mood and Cerebrovascular Function in Post-Menopausal Women; A 14-Week Randomised Placebo-Controlled Intervention Trial.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research · 2020